AirSculpt Technologies Inc

AirSculpt Technologies Inc(AIRS)股票分析

$1.245

-0.029 (-2.35%)收盤時

Loading chart…
最高
1.305
開盤
1.260
成交量加權均價
1.24
成交量
1.20M
市值
236.04M
最低
1.155
成交金額
1.48M
企業價值/稅息折舊攤銷前利潤(TTM)
12.65

AirSculpt Technologies, Inc. is engaged in providing body contouring treatment. The Company's treatment procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for healing with minimal bruising, tighter skin, and precise results. It offers a range of fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. It also offers AirSculpt +, which permanently removes fat and tightens the skin. Its treatment combines helium gas and radiofrequency energy to create a plasma equipped to correct sagging skin and restore a youthful, natural appearance.

AI 分析 of AirSculpt Technologies Inc (AIRS)

持有

Airsculpt Technologies Inc is currently not a strong buy due to its low current price of $1.275 and a very low RSI of 11.478, indicating oversold conditions. While analysts have set a price target of $5, the stock has experienced a significant decline of 87.66% over the past year, which raises concerns about its stability. The main risk is its negative earnings per share (EPS) of -0.02, which reflects ongoing financial struggles despite some improvements in gross margin to 54.39%.

估值指標

AirSculpt Technologies Inc(AIRS)目前預期本益比為 0.00,5 年平均預期本益比為 63.22。

預期本益比

合理
5 年均值 P/E
63.22
目前P/E
0.00
高估
358.74
低估
-232.30

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
18.56
目前EV/EBITDA
12.65
高估
38.18
低估
-1.05

預期股價營收比

低估
5 年均值 P/S
2.01
目前P/S
0.66
高估
3.07
低估
0.96

Alphio AI 對 AIRS 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%AIRS

$4.14

情境價格

基

基準

基準 · 50%AIRS

$3.25

情境價格

悲

悲觀

悲觀 · 25%AIRS

$2.81

情境價格

事件時間軸

2026-08-10 (ET)

06:30:00

Company Reports Q2 Revenue of $42.9M, Below Expectations

06:30:00

2026 Revenue Consensus at $153.19M, Adjusted EBITDA View Reduced to $12M-$14M

2026-05-08 (ET)

06:40:00

AirSculpt Reports Q1 Revenue of $39.39M

06:40:00

Reaffirms FY26 Adjusted EBITDA View of $15M-$17M

2026-04-02 (ET)

16:40:00

Major U.S. Averages Mixed as Oil Prices Rise to $111.54

資訊

AIRS 常見問題 —— 由 Alphio AI 解答

AirSculpt Technologies, Inc. is engaged in providing body contouring treatment. The Company's treatment procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for healing with minimal bruising, tighter skin, and precise results. It offers a range of fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. It also offers AirSculpt +, which permanently removes fat and tightens the skin. Its treatment combines helium gas and radiofrequency energy to create a plasma equipped to correct sagging skin and restore a youthful, natural appearance. It operates in the Healthcare sector (SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE industry).

Airsculpt Technologies Inc is currently not a strong buy due to its low current price of $1.275 and a very low RSI of 11.478, indicating oversold conditions. While analysts have set a price target of $5, the stock has experienced a significant decline of 87.66% over the past year, which raises concerns about its stability. The main risk is its negative earnings per share (EPS) of -0.02, which reflects ongoing financial struggles despite some improvements in gross margin to 54.39%.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易